Wren Therapeutics Company
Wren Therapeutics is a biopharmaceutical company based in Cambridge UK, focused on drug discovery and development for protein misfolding diseases, which include Alzheimer’s and Parkinson’s diseases, type-2 diabetes, and many rare forms of amyloidosis. Wren’s proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. Wren is using this platform to develop small molecule therapeutics for multiple protein misfolding diseases, including major neurological and rare disorders.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Zip:
11-50
Founded Date:
2016-01-01
Employees Number:
11-50
Acquisitions Number:
5
Investors Number:
40279740
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
contact@wrentherapeutics.com
Register and Claim Ownership